AntagomiR-based therapy for pulmonary arterial hypertension: MIRNA-152 increases pulmonary arterial hypertension via down regulation of its target gene, 13/February/2015, 22.24

Molecular therapy for Inflammatory Bowel disease (IBD): TGFβ preserves the functions of Beclin 1 and ATG5 and decreases tissue injury in inflammatory bowel disease (IBD) via down regulation of its target gene, 13/February/2015, 22.19
February 13, 2015
Natural product-based thearpy for cancer: Garlic suppresses the expression of oncoprotein Mcl-1 and increases the expression of proapoptotic protein BIM via down regulation of its target gene, 13/February/2015, 22.42
February 13, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Significance: This study suggests, for the first time, that MiRNA-152, by suppressing the expression of its target gene, it may increase pulmonary arterial hypertension. Thus, pharmacological formulations encompassing “MiRNA-152 inhibitors may be used to treat pulmonary arterial hypertension (PAH).

Amount: $ 300*

Undisclosed information: How MiRNA-152 increases pulmonary arterial hypertension

To citeBoominathan, AntagomiR-based therapy for pulmonary arterial hypertension: MIRNA-152 increases  pulmonary arterial hypertension via down regulation of its target gene, 13/February/2015,  22.24,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Comments are closed.